tiprankstipranks
Advertisement
Advertisement
MediciNova management to meet with Maxim
PremiumThe FlyMediciNova management to meet with Maxim
2M ago
MediciNova issues letter to shareholders
Premium
The Fly
MediciNova issues letter to shareholders
4M ago
MediciNova initiated with a Buy at Lucid Capital
Premium
The Fly
MediciNova initiated with a Buy at Lucid Capital
4M ago
MediciNova completes patient enrollment in MN-001-NATG-202 trial
PremiumThe FlyMediciNova completes patient enrollment in MN-001-NATG-202 trial
6M ago
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
Premium
The Fly
MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
6M ago
MediciNova completes patient enrollment in COMBAT-ALS Phase 2b/3 trial
Premium
The Fly
MediciNova completes patient enrollment in COMBAT-ALS Phase 2b/3 trial
7M ago
MediciNova enters $30M equity purchase agreement
PremiumThe FlyMediciNova enters $30M equity purchase agreement
9M ago
MediciNova provides enrollment update for two key ongoing clinical trials
Premium
The Fly
MediciNova provides enrollment update for two key ongoing clinical trials
9M ago
Medicinova Announces Results of Annual Stockholders Meeting
Premium
Company Announcements
Medicinova Announces Results of Annual Stockholders Meeting
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100